Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details)

v3.24.2.u1
Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Liabilities:    
Private warrants $ 13,377 $ 3,325
Assets:    
Derivative asset, statement of financial position   Prepaid expenses and other current assets
Fair Value, Recurring    
Liabilities:    
Private warrants 13,377 $ 3,325
Total liabilities 13,377 3,325
Assets:    
Total assets   0
Fair Value, Recurring | Committed equity facility    
Assets:    
Committed equity facility   0
Level 1 | Fair Value, Recurring    
Liabilities:    
Private warrants 0 0
Total liabilities 0 0
Assets:    
Total assets   0
Level 1 | Fair Value, Recurring | Committed equity facility    
Assets:    
Committed equity facility   0
Level 2 | Fair Value, Recurring    
Liabilities:    
Private warrants 0 0
Total liabilities 0 0
Assets:    
Total assets   0
Level 2 | Fair Value, Recurring | Committed equity facility    
Assets:    
Committed equity facility   0
Level 3 | Fair Value, Recurring    
Liabilities:    
Private warrants 13,377 3,325
Total liabilities $ 13,377 3,325
Assets:    
Total assets   0
Level 3 | Fair Value, Recurring | Committed equity facility    
Assets:    
Committed equity facility   $ 0